UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Samsung Biologics makes CDO partnership with Taiwanese bio-venture
Samsung Biologics said that it has entered into a contract developing organ...
by Lee Han-soo
|
2020-03-17 17:31
라인
Celltrion Healthcare launches anticancer biosimilar Herzuma in US
Celltrion Healthcare said Tuesday that the company has launched its antican...
by Lee Han-soo
|
2020-03-17 16:21
라인
‘Celltrion to invest ₩20 billion to develop COVID-19 cure in 6 months’
Celltrion said that it would start clinical trials on humans to come up wit...
by Lee Han-soo
|
2020-03-13 17:38
라인
SK Bioscience threatens MSD's sway over shingles vaccine market
SK Bioscience's shingles vaccine Skyzoster, launched only two years ago...
by Lee Han-soo
|
2020-03-12 17:05
라인
Bridge Biotherapeutics, Atomwise to develop new drugs using AI
Bridge Biotherapeutics said that it would partner up with Atomwise, a U.S. ...
by Lee Han-soo
|
2020-03-10 12:26
라인
Celltrion applies for approval of new Humira biosimilar to EMA
Celltrion said Monday that it has completed the application of its CT-P17, ...
by Shim Hyun-tai
|
2020-03-09 16:40
라인
Celltrion Healthcare’s 2019 sales top ₩1 trillion
Celltrion Healthcare said that it registered 1 trillion won ($840.6 million...
by Lee Han-soo
|
2020-03-06 17:31
라인
Samsung BioLogics, STCube to develop immunotherapies
Samsung BioLogics said that it has signed a contract development organizati...
by Lee Han-soo
|
2020-03-03 16:18
라인
Celltrion Healthcare presents Remsima SC in UK
Celltrion Healthcare, the distribution and marketing unit of Korea's bi...
by Lee Han-soo
|
2020-03-02 17:42
라인
HLB seeks new pipelines by taking over US biotech firm
HLB, a Kosdaq-listed firm, said it would seek to secure new pipelines other...
by Jeong Sae-im
|
2020-02-21 15:42
라인
Celltrion’s annual revenue surpassed ₩1 trillion in 2019
Celltrion, the nation’s leading biosimilar manufacturer, said its annual sa...
by Jeong Sae-im
|
2020-02-20 15:47
라인
Prescription of Celltrion’s Remsima SC started in Germany
Celltrion Healthcare, the distribution and marketing unit of Korea’s biosim...
by Jeong Sae-im
|
2020-02-18 16:05
라인
Korea University analyzes 5,000 cancer patients’ genomic data
Korea University’s state-supported precision medicine project group, dubbed...
by Kim Yun-mi
|
2020-02-11 15:49
라인
Sillajen's loss more than doubles due to Pexa-Vec trial failure
Sillajen’s losses more than doubled last year as the company failed its pha...
by Jeong Sae-im
|
2020-02-03 16:08
라인
Kolon CEO arrested for mislabeling Invossa’s ingredient
A local court issued an arrest warrant for Kolon Life Science CEO Lee Woo-s...
by Jeong Sae-im
|
2020-02-03 15:34
라인
Interpark embarks on organoid business
“We will develop organoid-based new medicines and realize customized precis...
by Park Gi-taek
|
2020-01-27 11:18
라인
Samsung BioLogics’ annual sales up 30% on contract research growth
Samsung BioLogics saw its earnings surge last year, as it pursued more cont...
by Jeong Sae-im
|
2020-01-23 14:47
라인
Celltrion Group to build biopharmaceutical plant in China
Celltrion Group said that it plans to build a biopharmaceutical factory in ...
by Lee Han-soo
|
2020-01-21 18:00
라인
Korea’s biopharma power shines at JP Morgan Healthcare meet
Korean pharmaceutical and biotech companies showed off their technological ...
by Jeong Sae-im
|
2020-01-17 15:20
라인
HLB stocks fall in after-hours trading due to interview on rivoceranib
HLB, a Kosdaq-listed firm, said it would introduce new anticancer pipelines...
by Jeong Sae-im
|
2020-01-16 15:46
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top